{
  "@context": [
    "file://domain/_contexts/base.jsonld",
    "file://domain/_contexts/medicine.jsonld"
  ],
  "@type": [
    "EducationalResource",
    "MedicalEntity"
  ],
  "@id": "aku-008-nonocclusive-mesenteric-ischemia",
  "metadata": {
    "version": "1.0.0",
    "created": "2025-12-30T04:10:00.000Z",
    "contributors": [
      "copilot-agent",
      "vascular-surgery-knowledge-base"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "last_updated": "2025-12-30T04:10:00.000Z",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pathology/mesenteric-ischemia",
    "type": "pathophysiology",
    "difficulty": "advanced",
    "importance": "critical",
    "aku_id": "008",
    "keywords": [
      "NOMI",
      "nonocclusive mesenteric ischemia",
      "splanchnic vasoconstriction",
      "low-flow state",
      "vasopressor-induced ischemia"
    ],
    "medical_specialty": "vascular_surgery",
    "isNativeDomain": true
  },
  "content": {
    "statement": "aku-008-nonocclusive-mesenteric-ischemia is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pathology Mesenteric-Ischemia that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding aku-008-nonocclusive-mesenteric-ischemia helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of aku-008-nonocclusive-mesenteric-ischemia include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of aku-008-nonocclusive-mesenteric-ischemia."
    }
  },
  "pathophysiology": {
    "mechanisms": [
      {
        "mechanism": "Sympathetic vasoconstriction",
        "description": "Alpha-1 receptor activation causes mesenteric arteriolar constriction",
        "triggers": [
          "Hypovolemia",
          "Cardiogenic shock",
          "Hemorrhage"
        ]
      },
      {
        "mechanism": "Vasopressor-induced",
        "description": "Exogenous catecholamines cause disproportionate splanchnic vasoconstriction",
        "triggers": [
          "Norepinephrine infusion",
          "Vasopressin",
          "High-dose dopamine"
        ]
      },
      {
        "mechanism": "Cardiac output reduction",
        "description": "Absolute reduction in blood available for splanchnic circulation",
        "triggers": [
          "Heart failure",
          "Post-cardiac surgery",
          "Massive PE"
        ]
      },
      {
        "mechanism": "Drug-induced",
        "description": "Direct mesenteric vasoconstriction",
        "triggers": [
          "Digitalis",
          "Cocaine",
          "Ergot alkaloids"
        ]
      }
    ],
    "vascular_changes": {
      "arteriolar_spasm": "Diffuse narrowing of small mesenteric arteries and arterioles",
      "appearance": "CTA shows pruning of distal branches with patent main vessels",
      "patchy_ischemia": "Non-territorial distribution due to microvascular involvement",
      "alternating_segments": "Skip lesions of viable and ischemic bowel"
    }
  },
  "risk_factors": {
    "critically_ill_ICU": {
      "frequency": "Most common setting",
      "examples": [
        "Septic shock requiring vasopressors",
        "Cardiogenic shock",
        "Post-cardiac surgery (especially valve surgery)",
        "ECMO patients",
        "Post-cardiopulmonary bypass"
      ]
    },
    "cardiac_conditions": {
      "examples": [
        "Acute myocardial infarction",
        "Severe heart failure",
        "Arrhythmias with low output"
      ]
    },
    "hypovolemic_states": {
      "examples": [
        "Hemorrhagic shock",
        "Severe dehydration",
        "Burns"
      ]
    },
    "medications": {
      "high_risk": [
        "Norepinephrine",
        "Epinephrine",
        "Vasopressin",
        "Digitalis"
      ],
      "moderate_risk": [
        "Dopamine (high dose)",
        "Phenylephrine"
      ],
      "other": [
        "Cocaine",
        "Ergotamine"
      ]
    },
    "hemodialysis": {
      "mechanism": "Intradialytic hypotension and ultrafiltration",
      "risk_period": "During or immediately after dialysis session"
    }
  },
  "clinical_presentation": {
    "challenges": [
      "Patient often sedated and unable to report symptoms",
      "Abdominal exam limited by sedation, mechanical ventilation",
      "Symptoms masked by underlying critical illness",
      "Often diagnosed late or at autopsy"
    ],
    "early_signs": [
      "Unexplained metabolic acidosis",
      "Rising lactate without other explanation",
      "Feeding intolerance, high gastric residuals",
      "Abdominal distension",
      "Bloody stool or nasogastric output"
    ],
    "late_signs": [
      "Peritonitis (if patient not paralyzed)",
      "Septic shock worsening",
      "Multi-organ failure progression"
    ],
    "laboratory_findings": {
      "lactate": "Rising, often >4 mmol/L",
      "metabolic_acidosis": "Anion gap acidosis",
      "leukocytosis": "Or leukopenia (poor prognostic sign)",
      "D_dimer": "Elevated (nonspecific)"
    }
  },
  "diagnosis": {
    "clinical_suspicion": "Most important - must think of NOMI in high-risk patients",
    "CTA_findings": {
      "main_vessels": "Patent celiac, SMA, IMA (no occlusion)",
      "branch_vessels": "Narrowed, irregular, pruned appearance",
      "bowel_findings": "May show mural thinning, pneumatosis, portal venous gas"
    },
    "angiography_findings": {
      "classic": "Diffuse arterial spasm with pruning of distal branches",
      "SMA_appearance": "Narrowed trunk with poor filling of arcades",
      "therapeutic_opportunity": "Can administer vasodilators directly"
    }
  },
  "treatment": {
    "fundamental_approach": "Treat the underlying cause and optimize cardiac output",
    "supportive": [
      "Volume resuscitation (carefully)",
      "Optimize cardiac output",
      "Reduce/eliminate vasopressors if possible",
      "Discontinue digitalis"
    ],
    "specific_therapy": {
      "intra_arterial_vasodilators": {
        "agent": "Papaverine, prostaglandin E1, glucagon",
        "route": "Catheter placed in SMA",
        "dose": "Papaverine 30-60 mg/hr",
        "duration": "24-48 hours or until clinical improvement"
      }
    },
    "surgical": {
      "role": "Limited - no anatomic lesion to fix",
      "indication": "Necrotic bowel requiring resection",
      "approach": "Resection of nonviable segments, damage control",
      "prognosis": "Very poor if surgery required"
    }
  },
  "prognosis": {
    "mortality": "50-90% (highest of all mesenteric ischemia types)",
    "factors": [
      "Delayed diagnosis",
      "Underlying critical illness",
      "Often represents multi-organ failure",
      "Limited therapeutic options"
    ],
    "survivors": "May have short-term survivors but high in-hospital mortality"
  },
  "prevention": {
    "strategies": [
      "Minimize vasopressor dose and duration",
      "Use dobutamine to support cardiac output when possible",
      "Avoid digitalis in low-flow states",
      "Early enteral feeding may be protective",
      "Monitor for early signs in high-risk patients"
    ],
    "surveillance": "Serial lactate monitoring in high-risk patients"
  },
  "relationships": {
    "prerequisites": [
      {
        "id": "urn:wskg:medicine:surgery:vascular:pathology:mesenteric-ischemia:001",
        "title": "Mesenteric Ischemia Overview",
        "strength": 1.0
      }
    ],
    "related": [
      {
        "id": "urn:wskg:medicine:critical-care:shock:001",
        "type": "causative_condition",
        "relationship": "Shock states are the primary cause of NOMI"
      }
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). aku-008-nonocclusive-mesenteric-ischemia. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  },
  "pedagogical": {
    "target_audience": [
      "vascular_surgery_residents",
      "critical_care_physicians",
      "cardiac_surgery_residents"
    ],
    "estimated_time": "25min",
    "learning_objectives": [
      "Define NOMI and understand its pathophysiology",
      "Identify high-risk patient populations",
      "Recognize the clinical and imaging features",
      "Understand treatment options and their limitations"
    ],
    "clinical_pearls": [
      "NOMI is the ICU's silent killer - look for it in high-risk patients",
      "Rising lactate in a patient on vasopressors = think NOMI",
      "Patent main vessels on CTA doesn't rule out mesenteric ischemia",
      "Prevention is more effective than treatment"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10",
      "codeValue": "K55.1",
      "description": "Chronic vascular disorders of intestine",
      "matchType": "relatedMatch"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "233934000",
      "description": "Non-occlusive mesenteric ischemia",
      "matchType": "exactMatch"
    }
  ]
}